Crescent Biopharma, Inc. (NASDAQ:CBIO – Free Report) – Analysts at HC Wainwright dropped their FY2025 EPS estimates for Crescent Biopharma in a report released on Monday, November 10th. HC Wainwright analyst M. Kapoor now forecasts that the biopharmaceutical company will post earnings of ($8.80) per share for the year, down from their previous estimate of [...]
HC Wainwright Has Negative Outlook for CBIO FY2025 Earnings
